Researchers have found an association between migraines and microbes that reduce nitrates. Analyzing data from the American Gut Project, they found that migraine sufferers harbored significantly more microbes in their mouths and guts with the ability to modify nitrates compared to people who do not get migraine headaches. 

By some estimates, about 2 billion tons of food, about 50 percent of all the food produced on the planet, is wasted before it ever reaches a human stomach.

That's bad, but science, like apples and potatoes that look more appealing for a longer time, can fix some of that, while better pesticides and scientific optimization can improve yields at the agriculture stage, if environmentalists would stop terrorizing people about food.

Yet a survey by the International Food Information Council (IFIC) Foundation finds something more worrisome now; many Americans are shockingly unaware of their own roles in contributing to the problem,.

The story of phosphoethanolamine (PHOS) in Brazil, which set off a widely publicized scientific debacle about the dangers of taking unproven compounds as medicines, shows once again that just because some miracle cure is touted in a foreign country doesn't make it real.

This fact is in defiance of anti-science groups convinced of an FDA/Big Pharma conspiracy against cures, but America remains the gold standard for legitimacy, and with good reason. While cancer patients and their advocates may find the process of cancer drug discovery to be opaque or frustrating, the authors of the policy paper argue that the process is an essential part of clinical research.

In a recent paper, of 81 overweight and obese women with type 2 diabetes who usually consumed diet beverages and were on a weight loss program, those who substituted water for diet beverages after their lunch for 24 weeks had a greater decrease in weight (-6.40 vs. -5.25 kg) and body mass index (-2.49 vs.

A novel computational approach to design has created a new compound that in laboratory studies has reduced deficits and neurodegenerative symptoms that underlie Parkinson’s disease.

In their study, the researchers describe how their compound, dubbed NPT100-18A, prevents the binding and accumulation of alpha-synuclein or α-syn in neuronal membranes, now considered a hallmark of Parkinson’s disease and a related disorder called dementia with Lewy bodies.

Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss. The gene therapy restored production of CLN3 protein in the stem cell-derived retinal neurons, as described in an article in Human Gene Therapy.